BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Fuji
Moodys
US Department of Justice
Fish and Richardson
Chubb
AstraZeneca
Cantor Fitzgerald
Cerilliant

Generated: January 17, 2018

DrugPatentWatch Database Preview

PRESAMINE Drug Profile

« Back to Dashboard

Which patents cover Presamine, and when can generic versions of Presamine launch?

Presamine is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PRESAMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.

US Patents and Regulatory Information for PRESAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Mallinckrodt
Accenture
McKesson
UBS
Novartis
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot